Artemis P Simopoulos, MD is the Founder and President of The Center for Genetics, Nutrition and Health (CGNH), a nonprofit educational organization in Washington, D.C. since 1990. A graduate of Barnard College, Columbia University, with a major in Chemistry, and a graduate of the Boston University School of Medicine, She is certified by the American Board of Pediatrics and is a member of the American Academy of Pediatrics, the Society for Pediatric Research, the American Pediatric Society, the Endocrine Society, the American Institute of Nutrition, the American Society for Clinical Nutrition, the American College of Nutrition, the North American Association for the Study of Obesity, the International Society for the Study of Fatty Acids and Lipids (ISSFAL), the International Society of Nutrigenetics/Nutrigenomics (ISNN) and the American Society of Human Genetics.
Dr. Burn is a successful senior scientist, leader and business executive with a lifelong mission and passion of improving the human condition by delivering products, cures and care to patients and their families. As a senior executive with extensive global industry and international management experience, he has a proven track record of success in Academia, Pharmaceutical R&D, Biotech, Notfor-Profit and Integrated Health Care organizations. With over 30 years of experience in pharmaceutical and nutritional R&D, in Academia, in Not-for - Profit and integrated Health Care organizations, he spearheaded many programs, from the gene to the clinics and through marketed products. Under his leadership multiple programs resulted in the successful identification of clinical candidate molecules, their evaluation in humans and subsequent
market introduction. Most recently Dr. Burn served as Professor of Pediatrics at the Sanford School of Medicine and as
CEO, President and Chairman of the Board of Metabolic & Cardiovascular Health. He also serves on several Boards of Directors and Scientific Advisory Boards of Universities, Biotech companies and Government agencies.
Obesity, Type 1 Diabetes, Type 2 Diabetes, Regeneration, Nutrition, Discovery and Development
Dr. Rao immigrated to the USA in 1965 and specialized in grain storage technology and obtained his Ph.D degree from the Kansas State University, Manhattan, Kansas. After working as a post-doctoral fellow at the Texas A& M University and University of Minnesota, he joined department of Pharmacology as an NIH fellow to get training in toxicology. He has been with the University of Minnesota Medical School for over 40 years. He is a naturalized US citizen and a tenured professor in the department of Laboratory Medicine & Pathology. He also has faculty appointments in Anesthesiology, Lillehei Heart Institute, and Biomedical Engineering Institute.
Manuel Velasco, M.D., is a Professor of Pharmacology at the Central University of Venezuela, School of Medicine, and Director of Clinical Pharmacology Unit (CPU) at the Vargas School of Medicine in Caracas, Venezuela. Before joining to CPU, he obtained his Fellowship in Medicine at Emory University School of Medicine, Atlanta, USA. Dr. Velasco obtained his Fellowship at the Royal College of Physicians of Edinburgh. and acquired considerable experience in the areas of nuclear transfer, embryonic stem cells, embryo micro manipulation and state-of-the-art genetic engineering techniques in Biostatistics, radioisotopes and advanced Clinical pharmacology in the Royal College of Physicians in Edinburgh, Scotland, UK.
Dr Parijat De is a Consultant Physician in Diabetes, Endocrinology, and Lipid Metabolism at City Hospital (Sandwell & West Birmingham NHS Trust), Birmingham.
He started as a Consultant Physician in January 2003 having trained as a Specialist Registrar in Wales. He has done his MD Medicine from India.
He has a wide interest and expertise in all aspects of Diabetes, especially in the field of Metabolic Medicine and Diabetes Renal disease. His special interest in Diabetes is Metabolic Syndrome as well as the growing problem of obesity including new oral and injectable therapies for weight loss.
Professor Byeong-Churl Jang received his BS degreefrom Department of Food Science and Technology, Chungnam National University, Daejeon, South Korea in 1993, and obtained his PhD degree from Pennington Biomedical Research Center (PBRC)/Department of Food Science in Louisiana State University (LSU), Baton Rouge, La, USA, in 1999. He worked as a Post doctor at Center for Vascular Biology (CVB), University of Connecticut Health Center (UCHC), Farmington, CT, USAin 1999-2002. In 2002-2017, he worked as Research Professor, Full-time Instructor, Assistant and Associate Professorat Department of Molecular Medicine, School of Medicine, Keimyung University, Daegu, South Korea, and currently he is a Professor in the institution.
Dr Itzik Harosh is the founder & CEO of Obe Therapy (January 2000 - present) a biotech dedicated to the discovery of new genes for obesity and diabetes treatment based on the lean phenotype and the development of molecules for the treatment of metabolic syndrome. Establish the concept to look for new genes associated to starvation phenotype based on rare genetic diseases for the treatment of obesity and type II diabetes.
Prior to the creation of Obe Therapy he was a Group leader in GSK in France where he learned the art of drug discovery, targets identification and validation.
Obesity, Diabetes, Lipidemia and Metabolic syndrome
Dr. Nonogaki has worked as a Postdoc Research Fellow at the University of California, San Francisco and the Scripps Research Institute, La Jolla. He has studied central serotonin network in the regulation of appetite and energy homeostasis. Lorcaserin (Belviq), a selective 5-HT2C receptor agonist, which is used for the treatment of obesity, is based on the original research works by Dr. Nonogaki et al. Current studies are to determine the physiological mechanisms and potential treatment for obesity, type 2 diabetes and their complications. He also developing novel medical devices for hypertension and diabetes.
Medical device in the treatment of diabetes, Hepatic glucose and lipid metabolism
Professor Li Ming Wen graduated from the Second Military Medical University (SMMU), Shanghai, China. After migrating to Australia, in 1994, he obtained Master of Medicine and PhD degrees from Sydney Medical School, the University of Sydney. He is Clinical Associate Professor at Sydney Medical School, University of Sydney, and also Adjunct Professor with School of Public Health, Fudan University and Faculty of Medicine, University of Tongji, China. Since 2006, Prof Wen has received > $5 million in peer-reviewed national and international competitive grants. He has published over 120 peer reviewed papers in high impact journals including BMJ, JAMA Pediatrics and IJO.
Clinical trials and practice in the areas of obesity prevention, Nutrition
Prof. Shehab Mahmoud Abd El-kader, PT, MPT, PhD in physical therapy for cardiopulmonary, metabolic, women health, and geriatrics, Faculty of Physical Therapy, Cairo University, Egypt, since 2000 . Recent research interests include the areas of Cardiothoracic Surgery, Respiratory Disorders, Metabolic Disorders , women health, caring for older people, cardiopulmonary disorders, geriatrics, hepatology and wound care. Prof. Shehab is interested in teaching Physical therapy for patients with respiratory disorders, geriatrics, hepatology and metabolic disorders.
Obesity, Diabetes, Cardio-Pulmonary Disorders and Geriatrics